CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 61 filers reported holding CABALETTA BIO INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,441 | +176.4% | 34,983 | +134.5% | 0.00% | – |
| Q2 2023 | $192,618 | +1337.8% | 14,920 | +821.0% | 0.00% | – |
| Q1 2023 | $13,397 | -6.3% | 1,620 | +4.8% | 0.00% | – |
| Q4 2022 | $14,300 | -56.7% | 1,546 | -96.9% | 0.00% | – |
| Q3 2022 | $33,000 | +175.0% | 50,000 | +5086.7% | 0.00% | – |
| Q3 2021 | $12,000 | +500.0% | 964 | +332.3% | 0.00% | – |
| Q2 2021 | $2,000 | -80.0% | 223 | -76.3% | 0.00% | – |
| Q1 2021 | $10,000 | -58.3% | 941 | -51.4% | 0.00% | – |
| Q4 2020 | $24,000 | +1100.0% | 1,937 | +1073.9% | 0.00% | – |
| Q3 2020 | $2,000 | -96.1% | 165 | -96.4% | 0.00% | – |
| Q2 2020 | $51,000 | +82.1% | 4,549 | +17.9% | 0.00% | – |
| Q1 2020 | $28,000 | -75.0% | 3,858 | -52.0% | 0.00% | – |
| Q4 2019 | $112,000 | – | 8,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |